EZZ Life Science Holdings Limited (ASX:EZZ)
Australia · Delayed Price · Currency is AUD 0.4100
-0.0050 (-1.20%)
Sep 18, 2026, 11:52 AM AEST
EZZ Life Science Holdings Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 46.28 | 66.87 | 66.44 | 37.14 | 15.02 |
| 46.28 | 66.87 | 66.44 | 37.14 | 15.02 | |
Revenue Growth | -30.79% | 0.65% | 78.88% | 147.26% | -32.60% |
Cost of Revenue | 15.01 | 17.15 | 15.5 | 8.61 | 7.51 |
Gross Profit | 31.27 | 49.72 | 50.95 | 28.53 | 7.51 |
Selling, General & Admin | 28.3 | 35.87 | 38.49 | 21.7 | 4.14 |
Other Operating Expenses | 4.01 | 3.41 | 2.35 | 2.03 | 1.46 |
Operating Expenses | 37.88 | 39.79 | 41.23 | 23.91 | 5.72 |
Operating Income | -6.61 | 9.93 | 9.72 | 4.62 | 1.78 |
Interest Expense | -0.02 | -0.03 | -0.02 | -0.01 | -0 |
Interest & Investment Income | - | 0.42 | 0.2 | 0.04 | 0 |
Currency Exchange Gain (Loss) | - | 0.24 | 0.07 | 0.22 | - |
Other Non Operating Income (Expenses) | 0.21 | 0.03 | - | 0.04 | - |
Pretax Income | -6.41 | 10.59 | 9.96 | 4.9 | 1.78 |
Income Tax Expense | -1.09 | 3.86 | 2.99 | 1.27 | 0.47 |
Net Income | -5.32 | 6.73 | 6.96 | 3.63 | 1.31 |
Net Income to Common | -5.32 | 6.73 | 6.96 | 3.63 | 1.31 |
Net Income Growth | - | -3.36% | 91.87% | 176.57% | -35.37% |
Shares Outstanding (Basic) | 47 | 46 | 43 | 43 | 43 |
Shares Outstanding (Diluted) | 47 | 46 | 43 | 43 | 43 |
Shares Change | 1.77% | 7.35% | 0.89% | 0.46% | 25.23% |
EPS (Basic) | -0.11 | 0.15 | 0.16 | 0.08 | 0.03 |
EPS (Diluted) | -0.11 | 0.15 | 0.16 | 0.08 | 0.03 |
EPS Growth | - | -9.99% | 90.19% | 175.31% | -48.37% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -8.79 | 4.13 | 5.73 | 3.91 | 1.9 |
Free Cash Flow Per Share | -0.19 | 0.09 | 0.13 | 0.09 | 0.04 |
Dividend Per Share | - | 0.040 | 0.035 | 0.020 | 0.004 |
Dividend Growth | - | 14.29% | 76.77% | 340.00% | 0% |
Gross Margin | 67.56% | 74.35% | 76.68% | 76.81% | 49.98% |
Operating Margin | -14.28% | 14.85% | 14.62% | 12.43% | 11.88% |
Profit Margin | -11.50% | 10.06% | 10.48% | 9.77% | 8.74% |
Free Cash Flow Margin | -19.00% | 6.17% | 8.63% | 10.53% | 12.62% |
EBITDA | -6.12 | 10.08 | 9.75 | 4.63 | 1.8 |
EBITDA Margin | -13.22% | 15.08% | 14.68% | 12.48% | 11.98% |
D&A For EBITDA | 0.49 | 0.15 | 0.03 | 0.02 | 0.02 |
EBIT | -6.61 | 9.93 | 9.72 | 4.62 | 1.78 |
EBIT Margin | -14.28% | 14.85% | 14.62% | 12.43% | 11.88% |
Effective Tax Rate | - | 36.42% | 30.07% | 25.93% | 26.26% |
Advertising Expenses | 25.97 | 32.27 | 37.23 | 20.56 | 2.97 |